0001415889-24-010963.txt : 20240417
0001415889-24-010963.hdr.sgml : 20240417
20240417161525
ACCESSION NUMBER: 0001415889-24-010963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240415
FILED AS OF DATE: 20240417
DATE AS OF CHANGE: 20240417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Winderlich Mark
CENTRAL INDEX KEY: 0002019241
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38869
FILM NUMBER: 24851248
MAIL ADDRESS:
STREET 1: C/O HOOKIPA PHARMA INC.
STREET 2: 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
CITY: NEW YORK
STATE: NY
ZIP: 10118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HOOKIPA Pharma Inc.
CENTRAL INDEX KEY: 0001760542
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 815395687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: 0114318906360
MAIL ADDRESS:
STREET 1: 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
CITY: NEW YORK
STATE: NY
ZIP: 10118
4
1
form4-04172024_040414.xml
X0508
4
2024-04-15
0001760542
HOOKIPA Pharma Inc.
HOOK
0002019241
Winderlich Mark
C/O HOOKIPA PHARMA INC.
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
NEW YORK
NY
10118
false
true
false
false
Chief Development Officer
0
Stock Option (Right to Buy)
0.76
2024-04-15
4
A
0
250000
0
A
2034-04-15
Common Stock
250000
250000
D
Stock Option (Right to Buy)
0.76
2024-04-15
4
A
0
50000
0
A
2034-04-15
Common Stock
50000
50000
D
25% of this option shall vest on April 15, 2025, with the remainder vesting in 12 equal quarterly installments thereafter.
/s/ Reinhard Kandera, Attorney-in-Fact
2024-04-17